Phenotypes associated with this allele
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm1(H1/tetO-RNAi:Pdpk1)Mrl mutation
(0 available);
any
Gt(ROSA)26Sor mutation
(944 available)
|
|
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm1(H1/tetO-RNAi:Pdpk1)Mrl mutation
(0 available);
any
Gt(ROSA)26Sor mutation
(944 available)
Gt(ROSA)26Sortm9(cre/ESR1)Arte mutation
(2 available);
any
Gt(ROSA)26Sor mutation
(944 available)
Ptentm1Hwu mutation
(16 available);
any
Pten mutation
(81 available)
|
|
|
mortality/aging
|
• tamoxifen-treated mice survive 57 days unlike control mice
|
immune system
|
• in tamoxifen-treated mice
|
|
• in tamoxifen-treated mice
|
|
• in tamoxifen-treated mice
|
|
• in tamoxifen-treated mice
|
|
• in tamoxifen-treated mice
|
neoplasm
|
• tamoxifen-treated mice develop T cell acute lymphoblastic leukemia unlike control mice
|
behavior/neurological
|
• in tamoxifen-treated mice
|
growth/size/body
|
• in tamoxifen-treated mice
|
|
• in tamoxifen-treated mice
|
|
• in tamoxifen-treated mice
|
integument
|
• scruffy coat in tamoxifen-treated mice
|
hematopoietic system
|
• in tamoxifen-treated mice
|
|
• in tamoxifen-treated mice
|
|
• in tamoxifen-treated mice
|
|
• in tamoxifen-treated mice
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm1(H1/tetO-RNAi:Pdpk1)Mrl mutation
(0 available);
any
Gt(ROSA)26Sor mutation
(944 available)
Ptentm1Hwu mutation
(16 available);
any
Pten mutation
(81 available)
Tg(Pbsn-cre)4Prb mutation
(2 available)
|
|
|
reproductive system
|
• in doxycycline-treated mice
|
|
• in doxycycline-treated mice
|
|
• in doxycycline-treated mice
|
|
• doxycycline-treated mice exhibit microinvasive tumors in the prostate gland unlike in Pdk1tm1Dral homozygotes
|
|
• doxycycline-treated mice exhibit increased proliferation in the prostate gland compared to in Pdk1tm1Dral homozygotes
|
neoplasm
|
• doxycycline-treated mice exhibit microinvasive tumors in the prostate gland unlike in Pdk1tm1Dral homozygotes
|
endocrine/exocrine glands
|
• in doxycycline-treated mice
|
|
• in doxycycline-treated mice
|
|
• in doxycycline-treated mice
|
|
• doxycycline-treated mice exhibit microinvasive tumors in the prostate gland unlike in Pdk1tm1Dral homozygotes
|
|
• doxycycline-treated mice exhibit increased proliferation in the prostate gland compared to in Pdk1tm1Dral homozygotes
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm1(H1/tetO-RNAi:Pdpk1)Mrl mutation
(0 available);
any
Gt(ROSA)26Sor mutation
(944 available)
Ptentm1.1Hwu mutation
(0 available);
any
Pten mutation
(81 available)
|
|
|
neoplasm
|
• in doxycycline-treated mice
|
|
• at 6 to 7 months of age in doxycycline-treated mice
|
endocrine/exocrine glands
|
• in doxycycline-treated mice
|